The physiological and genetic mechanisms responsible for normal placentation and how their perturbation impairs placental blood flow to cause fetal growth restriction (FGR) remain largely unknown. Adrenomedullin (Adm) is a peptide vasodilator that has significant roles during pregnancy. A genetically deficient Adm mouse line is presented as a genetically-induced model of FGR and phenotyping of this model will elucidate the role of Adm in pregnancy and fetal growth. The Iong term objectives of this grant, to reveal the role of Adm in reproduction and to identify genetic and physiological factors that contribute to mechanisms of FGR will be achieved in three aims.
Specific Aim I will test the hypothesis that local concentrations of Adm at the maternal-fetal interface are essential for normal placentation and fetal .qrowth. To distinguish between the maternal and fetal contribution of Adm, a novel approach of .qenetically predetermined blastocyst transfer will be used. Pregnancies will be monitored for physiological and pathological indications of preeclampsia and placentas will be analyzed by 3-Dimensional placental casts, histology, ultrasound Doppler and the molecular phenotyping approach described in Specific Aim 2.
Specific Aim 2 will develop and validate a novel method for characterizinq placental defects by quantitaion of surrogate gene expression markers to determine if there are common placental pathways that are disrupted in association with FGR. Validation and application of this high-throughput phenotyping screen will be done in collaboration with the N/H-funded Mouse Mutagenesis Center for Deve/opmental Defects at Bay or Col/ege of Medicine.
Specific Aim 3 will combine the novel methods of Aims 1 & 2 to ask how maternal chronic diseases, such as hypertension and preeclampsia, exacerbate FGR. Four hypertensive mouse lines, including a genetically-clamped renin transgenic line, a genetically-deficient NPRA line, a genetically-deficient eNOS line and a spontaneously preeclamptic BPH/5 line will be used. Quantitative and comparative evaluation of the phenotypes will identify common genetic mechanisms that underlie the association between maternal hypertension and FGR. Each of the Specific Aims addresses gaps in our current knowledge of the role of Adm in reproduction and the mechanisms underlying FGR. Thus, results from these studies will advance basic science, contribute to better human reproductive health and potentially identify therapeutic interventions that would favorably alter the course of fetal growth in humans.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research Project (R01)
Project #
5R01HD046970-05
Application #
7356014
Study Section
Special Emphasis Panel (ZHD1-MCHG-B (18))
Program Officer
Ilekis, John V
Project Start
2004-04-01
Project End
2010-01-31
Budget Start
2008-02-01
Budget End
2010-01-31
Support Year
5
Fiscal Year
2008
Total Cost
$274,724
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Physiology
Type
Schools of Medicine
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Li, Manyu; Schwerbrock, Nicole M J; Lenhart, Patricia M et al. (2013) Fetal-derived adrenomedullin mediates the innate immune milieu of the placenta. J Clin Invest 123:2408-20
Kadmiel, Mahita; Fritz-Six, Kimberly; Pacharne, Suruchi et al. (2011) Research resource: Haploinsufficiency of receptor activity-modifying protein-2 (RAMP2) causes reduced fertility, hyperprolactinemia, skeletal abnormalities, and endocrine dysfunction in mice. Mol Endocrinol 25:1244-53
Dackor, Jennifer; Caron, Kathleen M; Threadgill, David W (2009) Placental and embryonic growth restriction in mice with reduced function epidermal growth factor receptor alleles. Genetics 183:207-18
Li, Manyu; Wu, Yongqin; Caron, Kathleen M (2008) Haploinsufficiency for adrenomedullin reduces pinopodes and diminishes uterine receptivity in mice. Biol Reprod 79:1169-75
Fritz-Six, Kimberly L; Dunworth, William P; Li, Manyu et al. (2008) Adrenomedullin signaling is necessary for murine lymphatic vascular development. J Clin Invest 118:40-50
Dackor, Ryan; Caron, Kathleen (2007) Mice heterozygous for adrenomedullin exhibit a more extreme inflammatory response to endotoxin-induced septic shock. Peptides 28:2164-70
Caron, Kathleen; Hagaman, John; Nishikimi, Toshio et al. (2007) Adrenomedullin gene expression differences in mice do not affect blood pressure but modulate hypertension-induced pathology in males. Proc Natl Acad Sci U S A 104:3420-5
Gibbons, Carrie; Dackor, Ryan; Dunworth, William et al. (2007) Receptor activity-modifying proteins: RAMPing up adrenomedullin signaling. Mol Endocrinol 21:783-96
Dackor, Ryan; Fritz-Six, Kim; Smithies, Oliver et al. (2007) Receptor activity-modifying proteins 2 and 3 have distinct physiological functions from embryogenesis to old age. J Biol Chem 282:18094-9
Li, Manyu; Yee, Della; Magnuson, Terry R et al. (2006) Reduced maternal expression of adrenomedullin disrupts fertility, placentation, and fetal growth in mice. J Clin Invest 116:2653-62